fashion -WSS

fashion

author：entertainment 2025-10-01 15:28:15 - browse：51

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

leisure time

WSS

How are insurers handling Leqembi and related scans?

Alabama IVF ruling threatens families facing fatal genetic disease

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Alabama hospital puts IVF treatments on hold

How are insurers handling Leqembi and related scans?

PBM reform efforts get punted in Congress

Wikipedia

fashion

focus

Affirmative action in medical school literally saved lives

Britney Spears to release memoir, 'The Woman In Me,' later this year

At least 13 dead in Texas as scorching temps continue

After half a century, Israel moves to evict squatter from his cave home on the beach

Psychedelics group wrestles with new pharma identity

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Virginia high school admissions case could be legal follow

Companies helping big Covid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

hotspot

Dario to buy mental health app maker Twill in cash and stock deal

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

EU fines Illumina $475 million over Grail acquisition

NIH study of ME/CFS points to clear biological hallmarks

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

In utero gene editing: an explainer

leisure time

leisure time

hotspot

entertainment